Literature DB >> 20711583

[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"].

A V Rüsseler1, B Brors, T Fischer, J T Hartmann, W Hartmann, P Hohenberger, P Lichter, A Marx, G Mechtersheimer, R Penzel, M Renner, H-U Schildhaus, P Schirmacher, E Sievers, P Ströbel, E Wardelmann, E Ziesché, R Büttner.   

Abstract

To establish precise diagnostic algorithms and standardised treatment of sarcomas in specialized centers, the interdisciplinary research group KoSar (sarcoma competence network) has been funded by German Cancer Aid. A sarcoma tissue repository and a diagnostic reference center have been set up, presently containing about 1000 accurately diagnosed sarcomas of different entities. Significant gene expression profiles for synovial sarcomas, leiomyosarcomas, myxoid liposarcomas and a small profile for myxofibrosarcomas as well as a new classification of angiosarcomas were defined. We systematically searched for activated signal transduction pathways in sarcoma cell lines and xenograft transplant models and candidate targets for molecular therapies were identified. Based on these results first clinical studies have been initiated by the German Interdisciplinary Sarcoma Study Group (GISG).

Entities:  

Mesh:

Year:  2010        PMID: 20711583     DOI: 10.1007/s00292-010-1340-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  5 in total

1.  MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.

Authors:  Johanna Manner; Bernhard Radlwimmer; Peter Hohenberger; Katharina Mössinger; Stefan Küffer; Christian Sauer; Djeda Belharazem; Andreas Zettl; Jean-Michel Coindre; Christian Hallermann; Jörg Thomas Hartmann; Detlef Katenkamp; Kathrin Katenkamp; Patrick Schöffski; Raf Sciot; Agnieszka Wozniak; Peter Lichter; Alexander Marx; Philipp Ströbel
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

2.  Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.

Authors:  N Friedrichs; J Küchler; E Endl; A Koch; J Czerwitzki; P Wurst; D Metzger; J H Schulte; M I Holst; L C Heukamp; O Larsson; S Tanaka; A Kawai; E Wardelmann; R Buettner; T Pietsch; W Hartmann
Journal:  J Pathol       Date:  2008-12       Impact factor: 7.996

3.  Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.

Authors:  Chiara Mussi; Hans-Ulrich Schildhaus; Alessandro Gronchi; Eva Wardelmann; Peter Hohenberger
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

4.  Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene.

Authors:  H-U Schildhaus; T Cavlar; E Binot; R Büttner; E Wardelmann; S Merkelbach-Bruse
Journal:  J Pathol       Date:  2008-10       Impact factor: 7.996

5.  Genomic profiling reveals subsets of dedifferentiated liposarcoma to follow separate molecular pathways.

Authors:  Ralf J Rieker; Juergen Weitz; Burkhard Lehner; Gerlinde Egerer; Andrea Mueller; Bernd Kasper; Peter Schirmacher; Stefan Joos; Gunhild Mechtersheimer
Journal:  Virchows Arch       Date:  2009-12-29       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.